about
The search for cis-regulatory driver mutations in cancer genomesGenomic Classification of Cutaneous MelanomaWhole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanomaRevisiting determinants of prognosis in cutaneous melanoma.The functional relevance of somatic synonymous mutations in melanoma and other cancers.Recurrent inactivating RASA2 mutations in melanoma.Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies.Beyond the exome: the role of non-coding somatic mutations in cancer.The genomic landscape of cutaneous melanoma.Somatic driver mutations in melanoma.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma.The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma.Functional 5' UTR motif discovery with LESMoN: Local Enrichment of Sequence Motifs in biological Networks.How Ribosomes Translate Cancer.RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells.The ribosome, (slow) beating heart of cancer (stem) cell.
P2860
Q26781886-FFFA0A92-8260-49DE-A872-859939304BA2Q34670776-8C47FD1F-5A17-4F04-BBCE-C4C2BB35D986Q35176032-8C5E3679-D246-4672-99CE-348A7954F4B1Q36338825-656A2F32-E809-4FD5-883E-00ED7F4DB587Q36805023-F9B7C54D-C8A2-42FD-A753-7AE0A08A9722Q37112088-1F50250E-AE33-4E70-AC70-B49FD0B4E25BQ37687028-2D021842-8219-49AA-8706-EF81A7F9F2FDQ38645015-47B850E5-7496-425F-A977-EDAC3810CD21Q38718904-DC7EEEBC-6670-46A5-BC6A-94421B7ADD98Q38764368-A9C19880-A347-4ECF-9654-5B2BD5038EBAQ38838144-31AF8A8D-7D8D-4ACB-AF18-294F6A3B4B30Q38874383-A3FC29E3-D2A7-4028-A152-36637DACCFBEQ38986278-F9FD99C5-2477-4734-8910-2873D54A1BAAQ40200165-06454CB9-B534-44FF-9577-79979A9D2918Q41115366-69EB4A90-C0F6-429B-B289-B46BD81F8906Q47661739-8C762913-0C83-4EE7-8E0C-047E49061B9FQ47782255-771C658C-756A-4FA7-86DB-49A26686B946Q48251012-F8C5DA80-676A-4AEF-A0C5-6E94CA58CFA5Q52315005-6BF0B972-7D00-486F-8D63-4EF110ADDADA
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A highly recurrent RPS27 5'UTR mutation in melanoma.
@ast
A highly recurrent RPS27 5'UTR mutation in melanoma.
@en
type
label
A highly recurrent RPS27 5'UTR mutation in melanoma.
@ast
A highly recurrent RPS27 5'UTR mutation in melanoma.
@en
prefLabel
A highly recurrent RPS27 5'UTR mutation in melanoma.
@ast
A highly recurrent RPS27 5'UTR mutation in melanoma.
@en
P2093
P2860
P356
P1433
P1476
A highly recurrent RPS27 5'UTR mutation in melanoma.
@en
P2093
Jared J Gartner
Jeffrey E Gershenwald
John F Thompson
Ken Dutton-Regester
Michael A Davies
Nicholas K Hayward
Nouar Qutob
Rafi Emmanuel
Richard A Scolyer
Steven A Rosenberg
P2860
P304
P356
10.18632/ONCOTARGET.2048
P407
P577
2014-05-01T00:00:00Z